🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/08/2005 | 27,32 | 27,66 | 26,80 | 26,80 | -2,32% | 3,15% | 145.472 |
| 15/08/2005 | 26,24 | 29,01 | 26,16 | 27,44 | +4,57% | 10,84% | 214.962 |
| 12/08/2005 | 26,35 | 26,54 | 25,98 | 26,24 | -0,28% | 2,13% | 100.455 |
| 11/08/2005 | 26,28 | 26,39 | 25,60 | 26,31 | +0,14% | 2,99% | 109.004 |
| 10/08/2005 | 26,39 | 27,02 | 26,05 | 26,28 | -0,14% | 3,69% | 91.451 |
| 09/08/2005 | 26,72 | 26,91 | 26,09 | 26,31 | -0,85% | 3,08% | 199.654 |
| 08/08/2005 | 28,07 | 28,37 | 26,20 | 26,54 | -6,22% | 7,73% | 215.016 |
| 05/08/2005 | 30,28 | 30,32 | 28,00 | 28,30 | -5,85% | 7,66% | 297.811 |
| 04/08/2005 | 30,28 | 30,43 | 29,91 | 30,06 | -1,35% | 1,73% | 101.416 |
| 03/08/2005 | 30,54 | 30,73 | 30,09 | 30,47 | -0,85% | 2,08% | 124.981 |
| 02/08/2005 | 30,06 | 30,80 | 29,87 | 30,73 | +2,50% | 3,11% | 68.528 |
| 01/08/2005 | 29,08 | 30,39 | 28,15 | 29,98 | +2,69% | 7,72% | 174.513 |
| 29/07/2005 | 29,38 | 29,91 | 28,67 | 29,20 | -0,64% | 4,20% | 94.791 |
| 28/07/2005 | 28,75 | 29,46 | 28,60 | 29,38 | +2,21% | 2,99% | 180.792 |
| 27/07/2005 | 29,12 | 29,27 | 28,45 | 28,75 | -1,03% | 2,83% | 143.656 |
| 26/07/2005 | 29,53 | 29,87 | 28,67 | 29,05 | -0,64% | 4,06% | 156.052 |
| 25/07/2005 | 30,13 | 30,88 | 29,08 | 29,23 | -3,46% | 5,96% | 164.601 |
| 22/07/2005 | 31,07 | 31,07 | 29,94 | 30,28 | -1,70% | 3,61% | 179.322 |
| 21/07/2005 | 31,63 | 31,82 | 30,69 | 30,80 | -2,26% | 3,55% | 209.913 |
| 20/07/2005 | 31,07 | 31,52 | 30,32 | 31,52 | +1,45% | 3,86% | 205.852 |
| 19/07/2005 | 31,07 | 31,18 | 30,62 | 31,07 | +0,85% | 1,81% | 131.259 |
| 18/07/2005 | 31,44 | 31,82 | 30,62 | 30,80 | -2,14% | 3,81% | 356.320 |
| 15/07/2005 | 30,95 | 31,89 | 30,62 | 31,48 | +5,12% | 4,11% | 440.745 |
| 14/07/2005 | 29,20 | 30,32 | 28,82 | 29,94 | +4,03% | 5,13% | 288.032 |
| 13/07/2005 | 29,31 | 29,31 | 28,75 | 28,78 | -0,13% | 1,92% | 291.746 |
| 12/07/2005 | 29,42 | 29,87 | 28,18 | 28,82 | +0,00% | 5,73% | 604.384 |
| 11/07/2005 | 28,41 | 28,90 | 28,26 | 28,82 | +1,45% | 2,24% | 275.850 |
| 08/07/2005 | 26,69 | 28,45 | 26,58 | 28,41 | +6,75% | 7,01% | 231.420 |
| 07/07/2005 | 26,01 | 26,61 | 25,64 | 26,61 | +2,01% | 3,74% | 189.875 |
| 06/07/2005 | 27,25 | 27,25 | 26,01 | 26,09 | -3,86% | 4,53% | 208.390 |